Related references
Note: Only part of the references are listed.Mitochondrial pyruvate and fatty acid flux modulate MICU1-dependent control of MCU activity
Neeharika Nemani et al.
SCIENCE SIGNALING (2020)
High mitochondrial Ca2+ content increases cancer cell proliferation upon inhibition of mitochondrial permeability transition pore (mPTP)
Saverio Marchi et al.
CELL CYCLE (2019)
MiR-195 regulates mitochondrial function by targeting mitofusin-2 in breast cancer cells
Paresh Kumar Purohit et al.
RNA BIOLOGY (2019)
MicroRNA-195 reverses the resistance to temozolomide through targeting cyclin E1 in glioma cells
Hongqin Wang et al.
ANTI-CANCER DRUGS (2019)
Akt-mediated phosphorylation of MICU1 regulates mitochondrial Ca2+ levels and tumor growth
Saverio Marchi et al.
EMBO JOURNAL (2019)
New insights into the role of mitochondrial calcium homeostasis in cell migration
Vincent Paupe et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Metabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg Effect
Linchong Sun et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)
miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer
Xiaojie Yu et al.
CELL DEATH & DISEASE (2018)
FOXD1-dependent MICU1 expression regulates mitochondrial activity and cell differentiation
Santhanam Shanmughapriya et al.
NATURE COMMUNICATIONS (2018)
Subcellular Localization and Dynamics of the Bcl-2 Family of Proteins
Nikolay Popgeorgiev et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2018)
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rajesha Rupaimoole et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
MICU1 drives glycolysis and chemoresistance in ovarian cancer
Prabir K. Chakraborty et al.
NATURE COMMUNICATIONS (2017)
Expression of miR-195 is associated with chemotherapy sensitivity of cisplatin and clinical prognosis in gastric cancer
Rui Ye et al.
ONCOTARGET (2017)
Advances in the delivery of RNA therapeutics: from concept to clinical reality
James C. Kaczmarek et al.
GENOME MEDICINE (2017)
Linking metabolic reprogramming to therapy resistance in cancer
Andrea Morandi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2017)
Mitochondria and cancer chemoresistance
Flora Guerra et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2017)
The calcium-cancer signalling nexus
Gregory R. Monteith et al.
NATURE REVIEWS CANCER (2017)
Microtargeting cancer metabolism: opening new therapeutic windows based on lipid metabolism
Marta Gomez de Cedron et al.
JOURNAL OF LIPID RESEARCH (2016)
Functional roles of MICU1 and MICU2 in mitochondrial Ca2+ uptake
Jessica Matesanz-Isabel et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2016)
Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer
Shailendra Kumar Dhar Dwivedi et al.
ONCOTARGET (2016)
L- and D-lactate enhance DNA repair and modulate the resistance of cervical carcinoma cells to anticancer drugs via histone deacetylase inhibition and hydroxycarboxylic acid receptor 1 activation
Waldemar Wagner et al.
CELL COMMUNICATION AND SIGNALING (2015)
Serum miR-195 is a diagnostic and prognostic marker for osteosarcoma
Haikang Cai et al.
JOURNAL OF SURGICAL RESEARCH (2015)
MicroRNA-195-5p, a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells
Jian Wu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
miRWalk2.0: a comprehensive atlas of microRNA-target interactions
Harsh Dweep et al.
NATURE METHODS (2015)
MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1
Shaohua Xu et al.
ONCOTARGET (2015)
MicroRNA-195 inhibits proliferation, invasion and metastasis in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1
Richa Singh et al.
SCIENTIFIC REPORTS (2015)
miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells
Chunhui Liu et al.
PLOS ONE (2015)
MICU1 and MICU2 Finely Tune the Mitochondrial Ca2+ Uniporter by Exerting Opposite Effects on MCU Activity
Maria Patron et al.
MOLECULAR CELL (2014)
MicroRNA-195 acts as a tumor suppressor by directly targeting Wnt3a in HepG2 hepatocellular carcinoma cells
Yang Yang et al.
MOLECULAR MEDICINE REPORTS (2014)
Mitochondrial Calcium Uniporter Activity Is Dispensable for MDA-MB-231 Breast Carcinoma Cell Survival
Duane D. Hall et al.
PLOS ONE (2014)
MicroRNAs in cancer: biomarkers, functions and therapy
Josie Hayes et al.
TRENDS IN MOLECULAR MEDICINE (2014)
miR-195 inhibits the growth and metastasis of NSCLC cells by targeting IGF1R
Xiaoli Wang et al.
TUMOR BIOLOGY (2014)
miR-195 Targets HDGF to inhibit proliferation and invasion of NSCLC cells
Haizhou Guo et al.
TUMOR BIOLOGY (2014)
MICU1 Controls Both the Threshold and Cooperative Activation of the Mitochondrial Ca2+ Uniporter
Gyoergy Csordas et al.
CELL METABOLISM (2013)
Differential expression of miR-195 in esophageal squamous cell carcinoma and miR-195 expression inhibits tumor cell proliferation and invasion by targeting of Cdc42
Min-gen Fu et al.
FEBS LETTERS (2013)
MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer
Hongxia Deng et al.
GENE (2013)
MicroRNA-195 Suppresses Angiogenesis and Metastasis of Hepatocellular Carcinoma by Inhibiting the Expression of VEGF, VAV2, and CDC42
Ruizhi Wang et al.
HEPATOLOGY (2013)
Tumor glycolysis as a target for cancer therapy: progress and prospects
Shanmugasundaram Ganapathy-Kanniappan et al.
MOLECULAR CANCER (2013)
Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma
A. Bhattacharya et al.
ONCOGENE (2013)
MicroRNA-195 Inhibits the Proliferation of Human Glioma Cells by Directly Targeting Cyclin D1 and Cyclin E1
Wang Hui et al.
PLOS ONE (2013)
The Tumor-Suppressive miR-497-195 Cluster Targets Multiple Cell-Cycle Regulators in Hepatocellular Carcinoma
Mayuko Furuta et al.
PLOS ONE (2013)
EMRE Is an Essential Component of the Mitochondrial Calcium Uniporter Complex
Yasemin Sancak et al.
SCIENCE (2013)
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Patrick S. Ward et al.
CANCER CELL (2012)
MICU1 Is an Essential Gatekeeper for MCU-Mediated Mitochondrial Ca2+ Uptake that Regulates Cell Survival
Karthik Mallilankaraman et al.
CELL (2012)
MicroRNAs and the Warburg Effect: New Players in an Old Arena
Ping Gao et al.
CURRENT GENE THERAPY (2012)
MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression
Xiang Fei et al.
FEBS LETTERS (2012)
Cyclin-dependent kinase 4 is a novel target in micoRNA-195-mediated cell cycle arrest in bladder cancer cells
Yiwei Lin et al.
FEBS LETTERS (2012)
Downregulation of BCL2 by miRNAs augments drug-induced apoptosis - a combined computational and experimental approach
Richa Singh et al.
JOURNAL OF CELL SCIENCE (2012)
MCUR1 is an essential component of mitochondrial Ca2+ uptake that regulates cellular metabolism
Karthik Mallilankaraman et al.
NATURE CELL BIOLOGY (2012)
Targeting cancer metabolism: a bedside lesson
Kivanc Birsoy et al.
NATURE MEDICINE (2012)
MicroRNA-195 plays a tumor-suppressor role in human glioblastoma cells by targeting signaling pathways involved in cellular proliferation and invasion
Qian-Qian Zhang et al.
NEURO-ONCOLOGY (2012)
Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer
Xueqing Wang et al.
MEDICAL ONCOLOGY (2012)
Downregulated miR-195 Detected in Preeclamptic Placenta Affects Trophoblast Cell Invasion via Modulating ActRIIA Expression
Yang Bai et al.
PLOS ONE (2012)
Micro-RNA-195 and-451 Regulate the LKB1/AMPK Signaling Axis by Targeting MO25
Hao Chen et al.
PLOS ONE (2012)
microRNA-195 suppresses osteosarcoma cell invasion and migration in vitro by targeting FASN
Jian Hua Mao et al.
ONCOLOGY LETTERS (2012)
miR-34 – a microRNA replacement therapy is headed to the clinic
Andreas G. Bader
Frontiers in Genetics (2012)
Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation
Sophia Y. Lunt et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 27 (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Analysis of MiR-195 and MiR-497 Expression, Regulation and Role in Breast Cancer
Dan Li et al.
CLINICAL CANCER RESEARCH (2011)
Down-Regulation of Cyclin E1 Expression by MicroRNA-195 Accounts for Interferon-β-Induced Inhibition of Hepatic Stellate Cell Proliferation
Yumiko Sekiya et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Therapeutic targeting of cancer cell metabolism
Chi V. Dang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
MicroRNAs as a potential prognostic factor in gastric cancer
Baruch Brenner et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells
Lin Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Rethinking the Warburg Effect with Myc Micromanaging Glutamine Metabolism
Chi V. Dang
CANCER RESEARCH (2010)
3-Bromopyruvate: A New Targeted Antiglycolytic Agent and a Promise for Cancer Therapy
S. Ganapathy-Kanniappan et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2010)
Warburg effect in chemosensitivity: Targeting lactate dehydrogenase-A re-sensitizes Taxol-resistant cancer cells to Taxol
Ming Zhou et al.
MOLECULAR CANCER (2010)
Systemic miRNA-195 Differentiates Breast Cancer from Other Malignancies and Is a Potential Biomarker for Detecting Noninvasive and Early Stage Disease
Helen M. Heneghan et al.
ONCOLOGIST (2010)
miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer
Patsy Siok Hwa Soon et al.
CLINICAL CANCER RESEARCH (2009)
Targeting glucose metabolism with 2-deoxy-D-glucose for improving cancer therapy
B. S. Dwarakanath et al.
FUTURE ONCOLOGY (2009)
MicroRNA-195 Suppresses Tumorigenicity and Regulates G1/S Transition of Human Hepatocellular Carcinoma Cells
Teng Xu et al.
HEPATOLOGY (2009)
Cancer cell metabolism: Warburg and beyond
Peggy P. Hsu et al.
CELL (2008)
Specific growth rate versus doubling time for quantitative characterization of tumor growth rate
Esmaeil Mehrara et al.
CANCER RESEARCH (2007)
miR-15 and miR-16 induce apoptosis by targeting BCL2
A Cimmino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Blocking platelet-derived growth factor-D/platelet-derived growth factor receptor β signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model
L Xu et al.
CANCER RESEARCH (2005)
2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo
G Maschek et al.
CANCER RESEARCH (2004)
Mitochondria-targeting therapeutic strategies for overcoming chemoresistance and progression of cancer
T Morisaki et al.
CURRENT MEDICINAL CHEMISTRY (2003)
Molecular determinants of ovarian cancer plasticity
AK Sood et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Share Paper
